Paul Rickey
2020
In 2020, Paul Rickey earned a total compensation of $765.8K as Senior Vice President and Chief Financial Officer at Nivalis Therapeutics, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $169,799 |
|---|---|
| Option Awards | $214,016 |
| Salary | $382,000 |
| Total | $765,815 |
Rickey received $382K in salary, accounting for 50% of the total pay in 2020.
Rickey also received $169.8K in non-equity incentive plan and $214K in option awards.
Rankings
In 2020, Paul Rickey's compensation ranked 9,659th out of 13,090 executives tracked by ExecPay. In other words, Rickey earned more than 26.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,659 out of 13,090 | 26th |
Division Manufacturing | 4,152 out of 5,621 | 26th |
Major group Chemicals And Allied Products | 1,700 out of 2,254 | 25th |
Industry group Drugs | 1,489 out of 1,954 | 24th |
Industry Pharmaceutical Preparations | 1,097 out of 1,459 | 25th |
Source: SEC filing on April 29, 2022.
Rickey's colleagues
We found two more compensation records of executives who worked with Paul Rickey at Nivalis Therapeutics in 2020.